Stocks to sell

With meme stocks starting to tumble and Wall Street becoming much more skeptical about Clover Health (NASDAQ:CLOV), the outlook of CLOV stock has deteriorated meaningfully in recent weeks. Source: Shutterstock Meanwhile, Clover’s claims to be a high-tech disruptor are questionable, and the company continues to face Securites and Exchange Commission and Department of Justice probes,
0 Comments
With the stock-trading paradigm supposedly having shifted because of the novel coronavirus, fuel-cell electric vehicle (FCEV) specialist Plug Power (NASDAQ:PLUG)  looks awfully enticing. From its peak 2021 closing price of $73.18, PLUG stock is now down more than 60%. Of course, in this day and age of social media, such a decline represents about as
0 Comments
Nio (NYSE:NIO) has had one of the most incredible turnarounds in recent memory. The company’s initial public offering (IPO) was priced at $6 per share, and NIO stock stayed in the single digits following the IPO. Source: Sundry Photography / Shutterstock.com While Nio made a decent case about being able to beat Tesla (NASDAQ:TSLA) in
0 Comments
After an impressive run in this year’s first half, the stock of cryptocurrency mining company Marathon Digital Holdings (NASDAQ:MARA) stock looks to now be played out.  Source: Shutterstock The company specializes in mining Bitcoin (CCC:BTC-USD) and other cryptocurrencies by solving cryptographic equations with ultra-powerful computers has enjoyed a spectacular run in the past six months. Year-to-date,
0 Comments
Investors will conclude that Workhorse Group’s (NASDAQ:WKHS) strong rally from single-digit lows this year is irrational, but traders won’t overthink the strong gains from WKHS stock recently. Source: rblfmr / Shutterstock.com The clean energy and electric vehicle sector peaked in February. As prices fell to lows not seen since last year, speculators emerged to bet
0 Comments
Other than a massive trading spike in Feb. 2020 to $24.90, Vaxart (NASDAQ:VXRT) has gone nowhere. A mid-June upgrade from Piper Sandler to an “overweight” rating temporarily lifted VXRT stock, but its price remains low. Source: Photo courtesy of Vaxart, Inc. When vaccines are making headlines every day, why are Vaxart shares underperforming? And why
0 Comments